drugset / Trial / NCT05357911
A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin
NaSingle-groupOpen-labelTreatment
Summary
AB-106-C111 is China-only study, for investigating the drug interaction between AB-106 and P-gp substrate (Digoxin). （n=16）
Timeline
- Start
- 2021-07-13
- Primary completion
- 2021-08-20
- Completion
- 2021-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AB-106 | Small molecule | 600 mg | — |
| Subject | Digoxin | Other / unclassified | 0.25 mg | — |